Echo IQ issues 1 million new shares through option exercise

The latest update is out from EchoIQ Limited ( (AU:EIQ) ).

Echo IQ Limited has issued 1,000,000 fully paid ordinary shares following the exercise of unlisted options priced at $0.35 and expiring in June 2028, with the new shares forming part of its existing class quoted on the ASX. The company confirmed the issuance was conducted without a prospectus under relevant Corporations Act provisions, stated it is compliant with its continuous disclosure and financial reporting obligations, and reported there is no excluded information, signalling routine capital structure management with no undisclosed material developments for investors.

This share issue via option exercise modestly increases Echo IQ’s equity base and reflects the utilisation of previously granted unlisted options, which may provide additional funding flexibility without a separate capital raising process. The cleansing notice ensures the new shares can be traded on-market without further disclosure, supporting liquidity for investors while reinforcing the company’s adherence to Australian regulatory and governance standards.

The most recent analyst rating on (AU:EIQ) stock is a Hold with a A$0.90 price target. To see the full list of analyst forecasts on EchoIQ Limited stock, see the AU:EIQ Stock Forecast page.

More about EchoIQ Limited

Echo IQ Limited is an Australian AI and medical technology company based in Sydney that uses AI-driven technology and proprietary software to improve decision making in cardiology. The company focuses on applying advanced analytics to cardiac imaging and related data to support more accurate diagnosis and treatment planning in heart care.

Average Trading Volume: 3,224,477

Technical Sentiment Signal: Buy

Current Market Cap: A$569.4M

See more insights into EIQ stock on TipRanks’ Stock Analysis page.